AgeneBio AgeneBio is a pharmaceutical company dedicated to developing therapeutics that prevent neurodegeneration, preserve and restore cognitive brain function. | ![]() Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. | ![]() Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. | PharmatrophiX PharmatrophiX is a company developing small molecule drugs for
neurodegenerative and other diseases. | |
Founding Date | Founding Date 2008 | Founding Date 2005 | Founding Date 2013 | Founding Date 2005 |
Type | Type Private | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Baltimore, US HQ Baltimore, US | Locations Rockville, US HQ | Locations San Francisco, US HQ | Locations HQ |
Employees | Employees 4 | Employees 6527% increase | Employees 2382% decrease | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.9 b | Valuation ($) 495.3 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $719m (FY, 2025) | Revenue (est.) $21m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($38.6m) (FY, 2025) | Net income ($142.9m) (FY, 2025) | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round $ 3.4m (over 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 10.3m (over 10 years ago) |
Total funding raised | Total funding raised $ 9.5m | Total funding raised $ 69.5m | Total funding raised $ 194.5m | Total funding raised N/A |

Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View company
Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases.
View companyPharmatrophiX is a company developing small molecule drugs for neurodegenerative and other diseases.
View company